What is LOPJLB’s current signal on CVKD?

LOPJLB’s latest quantitative signal on Cadrenal Therapeutics, Inc. Common Stock (CVKD) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CVKD in?

Cadrenal Therapeutics, Inc. Common Stock (CVKD) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Cadrenal Therapeutics, Inc. Common Stock (CVKD) do?

Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease an…